Dr. Thomas Seyfried
PhD · Medical Researcher
Groundbreaking researcher reframing cancer and chronic disease as metabolic, mitochondrial dysfunctions rather than purely genetic.
"
Core Thesis
"Cancer is a metabolic disease rooted in mitochondrial dysfunction. By restricting fermentable fuels (glucose and glutamine), we can starve damaged cells and support systemic cellular energy."
Metabolic Oncology
Dr. Thomas Seyfried’s research challenges the genetic theory of cancer, demonstrating the profound impact of mitochondrial health and ketogenic metabolic therapy on cellular resilience.
Key Protocols
- Therapeutic carbohydrate restriction (Ketogenic diet)
- Calorie restriction and fasting to target damaged cells
- Press-Pulse therapeutic strategies